Search

Carboxylated Psilocybin Derivatives and Methods of Using (US12605361B2)

USPTO granted patent US12605361B2 to Enveric Biosciences Canada Inc. covering carboxylated psilocybin derivative compounds and pharmaceutical and recreational drug formulations containing the same. The patent contains 18 claims and is based on Application No. 18227688 filed July 28, 2023. This grant confers exclusive IP rights to the assignee and does not create compliance obligations for third parties.